OakChart

Medpace Holdings Inc

MEDPHealthcare·Diagnostics & Research·USA·Large·NASD·Nov 11 • 3:59 PM ET

664.77+0.23 (0.03%)
2026-11-12 01:00 CET
Market cap
18,588.31 USD m
Revenue, TTM
2,838.39 USD m
Net income, TTM
517.83 USD m
Free cash flow, TTM
667.63 USD m
EPS diluted, TTM
18.04
P/E
36.85
Compare

Price

MEDP against its 20, 50 and 200-day averages
2050200beat
400.00500.00600.00700.00589K1.2MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MEDPclose 664.7720-day 655.3250-day 627.03200-day 531.41664.7752w high

4.2% under the 52-week high of 693.97 on 28 Oct 2026. 52-week low 373.00 on 23 Apr 2026. Last 15 sessions, 9.8% high to low

Volume 0.52× normal · the line is the 50-bar volume average

Profile

MEDP
52-week range, 91% of the way up
373693.97

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: North America, Europe, Asia, South America, Africa and Australia. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

IndexRUI
Employees6200
IPOAug 11, 2016
Beta1.11
ATR, 14d21.11
Rel volume0.52
Short float6.09%
Insider own18.79%
Inst own88.87%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap18.59B
Enterprise Value18.06B
Income517.83M
Sales2.84B
Book/sh20.97
Cash/sh25.22
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees6200
IPOAug 11, 2016

Ratios

P/E36.85
Forward P/E33.75
PEG2.60
P/S6.55
P/B31.70
P/C26.36
P/FCF27.85
EV/EBITDA28.47
EV/Sales6.36
Quick Ratio0.83
Current Ratio0.83
Debt/Eq0.29
LT Debt/Eq0.25
Option/ShortYes / Yes

Earnings

EPS (ttm)18.04
EPS next Y19.70
EPS next Q4.83
EPS this Y19.38%
EPS next Y7.98%
EPS next 5Y12.99%
EPS past 3/5Y28.02% 31.79%
Sales past 3/5Y20.12% 22.27%
EPS Y/Y TTM25.24%
Sales Y/Y TTM20.35%
EPS Q/Q25.63%
Sales Q/Q8.50%
EarningsOct 21 AMC
EPS/Sales Surpr.9.11% 0.21%

Ownership

Insider Own18.79%
Insider Trans-6.65%
Inst Own88.87%
Inst Trans2.00%
ROA25.54%
ROE117.88%
ROIC70.84%
Gross Margin28.18%
Oper. Margin21.39%
Profit Margin18.24%
SMA201.44%
SMA506.02%
SMA20025.09%
Trades-

Technical

Shs Outstand27.90M
Shs Float22.72M
Short Float6.09%
Short Ratio5.33
Short Interest1.38M
52W High693.97 -4.21%
52W Low373.00 78.22%
Volatility3.68% 3.54%
ATR (14)21.11
RSI (14)55.86
Beta1.11
Rel Volume0.52
Avg Volume259.73K
Volume134,609

Performance

Perf Week1.22%
Perf Month9.00%
Perf Quarter14.23%
Perf Half Y56.87%
Perf YTD18.36%
Perf Year10.29%
Perf 3Y141.42%
Perf 5Y200.84%
Perf 10Y1835.28%
Recom2.86
Target Price674.75
Prev Close664.54
Price664.77
Change %0.03%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 30, 2026ResumedUUBSNeutral$673+1.2%
Jul 08, 2026DowngradeRRobert W. BairdOutperform → Neutral$547-17.7%
Jul 07, 2026DowngradeJJefferiesBuy → Hold$515-22.5%
Mar 06, 2026UpgradeBBarclaysUnderweight → Equal Weight$500-24.8%
Mar 03, 2026InitiatedRRBC Capital MktsOutperform$522-21.5%
Feb 18, 2026UpgradeTTD CowenSell → Hold$419-37.0%
Feb 13, 2026UpgradeJJefferiesHold → Buy$560-15.8%
Feb 10, 2026UpgradeRRobert W. BairdNeutral → Outperform$564-15.2%
Nov 13, 2025InitiatedBBMO Capital MarketsMarket Perform$600-9.7%
Oct 02, 2025DowngradeBBarclaysEqual Weight → Underweight$425-36.1%

Peers

Mkt cap
TickerCompanyMkt cap
ICLRIcon Plc14.96B
IQVIQVIA Holdings Inc45.24B
FTREFortrea Holdings Inc1.97B
LHLabcorp Holdings Inc30.23B
CRLCharles River Laboratories International Inc16.42B
TMOThermo Fisher Scientific Inc265.92B
VEEVVeeva Systems Inc49.34B
TEMTempus AI Inc14.49B
CERTCertara Inc1.79B
AZTAAzenta Inc2.14B

Insider trading

latest 14 of 95
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
EWALD STEPHEN PGeneral Counsel & Corp. Secy.Oct 29 '26Sale690.001,245859,05019,098Nov 02 06:24 PM
EWALD STEPHEN POfficerOct 29 '26Proposed Sale690.001,245859,050Oct 29 03:36 PM
BURWIG SUSAN EExec. VP, OperationsOct 26 '26Option Exercise166.7332854,68757,952Oct 28 04:23 PM
BURWIG SUSAN EExec. VP, OperationsOct 26 '26Sale677.0016,06010,872,62057,624Oct 28 04:23 PM
BURWIG SUSAN EExec. VP, OperationsOct 27 '26Sale677.003,9402,667,38054,012Oct 28 04:23 PM
BURWIG SUSAN EOfficerOct 27 '26Proposed Sale677.003,9402,667,380Oct 27 10:23 AM
BURWIG SUSAN EOfficerOct 26 '26Proposed Sale677.0016,06010,872,620Oct 26 04:24 PM
BURWIG SUSAN EExec. VP, OperationsOct 21 '26Option Exercise166.732,700450,17173,684Oct 23 04:11 PM
BURWIG SUSAN EExec. VP, OperationsOct 12 '26Option Exercise166.733,000500,19070,984Oct 14 04:14 PM
BURWIG SUSAN EExec. VP, OperationsOct 07 '26Option Exercise166.732,000333,46067,984Oct 09 04:14 PM
Troendle August J.President & CEOSep 29 '26Sale621.0226,70116,581,855360,191Oct 01 05:43 PM
Troendle August J.President & CEOSep 30 '26Sale625.4721,96613,739,074338,225Oct 01 05:43 PM
Troendle August J.President & CEOSep 28 '26Sale620.072,4101,494,369386,892Sep 29 04:13 PM
Troendle August J.President & CEOSep 25 '26Sale620.6015495,572389,302Sep 29 04:13 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
XMHQInvesco S&P MidCap Quality ETFAUM: 5.81B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IBBiShares Biotechnology ETFAUM: 11.36B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
IJKiShares S&P Mid-Cap 400 Growth ETFAUM: 10.46B
IWPiShares Russell Mid-Cap Growth ETFAUM: 18.09B

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-214.8404.4364.840716714.4711
2026Q22026-07-224.2503.9784.250707.33689.5110
2026Q12026-04-224.2803.9214.277706.6697.610
2025Q42026-02-094.6704.1854.666708.45689.3110
2025Q32025-10-223.8603.5353.857659.96419
2025Q22025-07-213.1002.9833.097603.31538.779
2025Q12025-04-213.6703.0603.673558.57526.348
2024Q42025-02-103.6702.9393.671536.6534.777
2024Q32024-10-213.0102.7713.005533.32540.997
2024Q22024-07-222.7502.5392.754528.1528.47
2024Q12024-04-223.2002.4663.205511.04512.396
2023Q42024-02-122.4602.2212.459498.4498.725
2023Q32023-10-232.2202.0462.220492.5475.795
2023Q22023-07-241.9301.9141.933460.87433.755
2023Q12023-04-242.2701.8152.265434.07401.815
2022Q42023-02-132.1201.7862.117394.1386.015

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY3.0202.9192.666860.97851.66
2020FY3.8403.7433.843925.93912.22
2021FY4.8104.7804.8121,1421,143
2022FY7.2806.9697.2831,4601,452
2023FY8.8808.6428.8761,8861,886
2024FY12.63011.93612.6302,1092,106
2025FY15.28014.80515.2802,5302,511
2026FY-18.241--2,850
2027FY-19.696--3,017
2028FY-22.041--3,278
2029FY-24.457--3,497
2030FY-27.323--3,914

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-231123718.4710725.04
2026Q4S2026-10-221123718.4710725.04
2026Q4S2026-10-211100720.89708.45738.04
2026Q4S2026-10-061100720.89708.45738.04
2026Q4S2026-10-0511100720.89708.45738.04
2026Q4S2026-09-2811100720.89708.45738.04
2026Q4S2026-09-1610100720.42708.45737.83
2026Q4S2026-09-1110100720.42708.45737.83
2026Q4S2026-07-2410100720.42708.45737.83
2026Q4S2026-07-2310100720.42708.45737.83
2026Q4S2026-07-221000694.39674.09709.7
2026Q4S2026-07-141000694.39674.09709.7
2026Q4S2026-07-071000694.7674.09709.7
2026Q4S2026-07-061007694.8674.09709.75

Estimate history

EPS, annual0.981.9752.6663.8434.8127.2838.87612.6315.27818.0377
Period201720182019202020212022202320242025TTM
EPS, quarterly3.0053.6713.6733.0973.8574.6664.2774.254.845
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual436.152704.589860.969925.9251142.3771459.9961885.8422109.0542530.2342838.39
Period201720182019202020212022202320242025TTM
Sales, quarterly533.317536.589558.57603.311659.903708.45706.604707.331716
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual35.26735.46635.86535.33535.82731.0230.68230.56128.30127.897
Period201720182019202020212022202320242025MRQ
Shares, quarterly31.01230.56129.76628.01928.09828.30128.4927.84127.897
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,838.392,530.232,109.051,885.841,460.001,142.38925.92860.97704.59
Cost of Goods Sold Incl. D&A2,038.551,797.741,482.001,387.661,049.90835.34666.73638.46527.86
Gross Profit799.84732.49627.05498.18410.10307.04259.20222.51176.73
Selling, General and Administrative Excl. Other192.70197.56180.18161.35131.40108.4292.1695.2575.68
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income607.14534.93446.87336.82278.70198.62167.04127.26101.05
Interest Expense-0.00-0.492.900.10-1.578.16
Unusual Expense0.000.000.000.000.000.000.00-0.00
Net Income Before Taxes626.99542.38475.92335.68282.86201.85168.53124.8393.95
Income Taxes109.1791.2571.5452.8737.4920.0023.1524.3920.77
Consolidated Net Income517.83451.12404.34282.62245.21181.39144.93100.1672.89
Net Income From Continuing Operations517.83451.12404.34282.62245.21181.39144.93100.1672.89
Net Income517.83451.12404.34282.62245.21181.39144.93100.1672.89
EPS (Recurring)18.2515.2812.638.887.284.813.842.671.97
EPS (Basic, Before Extraordinaries)18.3615.6413.069.207.575.064.072.792.05
EPS (Diluted)18.0415.2812.638.887.284.813.842.671.97
EBITDA634.46563.06476.12363.15319.05236.02200.49150.45139.85
Non-Operating Income (Expense)19.867.4429.05-0.667.073.341.49-0.861.06
Other After Tax Adjustments0.000.00-0.04-0.19-0.16-0.46-0.46-0.28-0.29
Stock Option Compensation Expense17.7727.4820.1616.2116.9210.5610.0615.145.13
Price To Earnings Ratio36.8436.8429.0935.9232.5845.2136.2231.5826.74
Price To Sales Ratio6.246.555.045.184.907.185.673.672.77
Gross Margin28.1828.9529.7326.4228.0926.8827.9925.8425.08
Operating Margin21.3921.1421.1917.8619.0917.3918.0414.7814.34
Net Margin18.2417.8319.1714.9916.8015.8815.6511.6310.35
Shares Outstanding27.9028.3030.5630.6831.0235.8335.3335.8735.47
Market Capitalization18,588.3118,588.3110,326.249,405.386,605.937,821.814,979.423,028.681,884.57

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue716.00707.33706.60708.45659.90603.31558.57536.59
Cost of Goods Sold Incl. D&A498.69512.40517.18510.26470.01430.31387.15365.78
Gross Profit217.31194.93189.42198.19189.89173.00171.42170.81
Selling, General and Administrative Excl. Other51.7748.1047.9244.9248.0846.6657.9045.43
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income165.54146.82141.50153.27141.81126.33113.52125.38
Interest Expense0.00--0.00----
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes170.91151.66147.59156.83142.84124.54118.17133.88
Income Taxes33.4530.3023.7221.7031.7034.283.5816.86
Consolidated Net Income137.46121.36123.87135.13111.1490.26114.59117.02
Net Income From Continuing Operations137.46121.36123.87135.13111.1490.26114.59117.02
Net Income137.46121.36123.87135.13111.1490.26114.59117.02
EPS (Recurring)4.844.254.284.673.863.103.673.67
EPS (Basic, Before Extraordinaries)4.924.314.354.783.953.163.773.78
EPS (Diluted)4.844.254.284.673.863.103.673.67
EBITDA172.12153.53148.41160.40148.86133.35120.45132.88
Non-Operating Income (Expense)5.374.846.093.561.03-1.804.658.50
Other After Tax Adjustments0.000.000.000.000.000.000.00-0.00
Stock Option Compensation Expense6.013.433.894.445.004.7013.344.65
Price To Earnings Ratio36.8433.3231.4039.2838.2423.9524.1229.09
Price To Sales Ratio6.245.445.196.436.284.104.415.02
Gross Margin30.3527.5626.8127.9728.7828.6730.6931.83
Operating Margin23.1220.7620.0321.6321.4920.9420.3223.37
Net Margin19.2017.1617.5319.0716.8414.9620.5221.81
Shares Outstanding27.9027.8428.4928.3028.1028.0229.7730.56
Market Capitalization18,588.3115,124.9313,628.4215,820.6714,444.309,020.849,282.9310,326.24

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments497.05669.44245.4528.27461.30277.77131.9223.2826.49
Short Term Receivables402.08296.44298.40253.40186.43160.96155.66133.4583.08
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets90.5063.3549.9852.2943.1834.9229.4521.3820.40
Total Current Assets989.621,029.23593.83333.96690.91473.65317.03178.11129.97
Net Property, Plant & Equipment248.87252.26265.39248.92222.71198.8399.4452.2648.74
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets695.82696.76698.21700.40703.76708.87716.75730.16759.72
Deferred Tax Assets19.22100.3674.4448.0825.130.540.380.716.34
Other Assets21.9422.2524.9721.1317.428.799.486.695.94
Total Assets1,975.472,100.871,656.831,352.491,659.931,390.681,143.07967.93950.72
Short Term Debt Incl. Current Port. of LT Debt23.2123.2922.3669.2716.2815.8910.982.1016.50
Accounts Payable28.1432.5331.8733.0725.6826.5522.4016.7416.67
Other Current Liabilities1,292.401,048.74870.90701.13515.26397.67309.62238.19159.53
Total Current Liabilities1,343.751,104.55925.13803.47557.22440.11343.00257.03192.71
Long Term Debt113.64126.23142.12138.87130.97115.1445.21104.20231.71
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities9.658.507.604.873.8815.6514.258.960.56
Other Liabilities49.3536.0323.0218.9014.9513.9914.328.0422.21
Total Liabilities1,516.401,275.321,097.88966.11707.01584.90416.79378.23447.19
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity459.07825.54558.95386.39952.93805.78726.28589.70503.53
Total Shareholders Equity459.07825.54558.95386.39952.93805.78726.28589.70503.53
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity459.07825.54558.95386.39952.93805.78726.28589.70503.53
Total Liabilities & Stockholders Equity1,975.472,100.871,656.831,352.491,659.931,390.681,143.07967.93950.72
Book Value Per Share16.2227.0118.2212.4626.6022.8020.2516.6314.28
Tangible Book Value Per Share-8.374.21-4.54-10.126.952.740.27-3.96-7.26
Full-Time Employees6,2005,9005,9005,2004,5003,6003,5002,9002,500
Price to Book Ratio31.6911.6919.9718.888.186.104.153.182.46
Return on Assets22.1321.5218.7816.2811.8911.449.497.604.05
Return on Equity70.2358.4159.7936.6220.6318.9215.2213.347.01
Return on Invested Capital78.7742.4840.3146.6816.7415.7412.9810.505.31
Quick Ratio0.740.930.640.421.241.080.920.690.67
Current Ratio0.740.930.640.421.241.080.920.690.67

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income517.83451.12404.39282.81245.37181.85145.38100.4473.19
Depreciation27.3328.1229.2526.3340.3637.4133.4523.1938.80
Other Funds (Non Cash)46.4756.9244.6342.8719.2914.4813.0632.601.05
Funds from Operations637.24616.95451.63326.89282.00196.62192.42166.28116.98
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital85.8096.28157.18106.49106.0666.7166.2635.5939.60
Cash from Operating Activities723.05713.22608.82433.37388.05263.33258.68201.87156.58
Capital Expenditures-55.42-31.36-36.55-36.65-36.88-28.27-31.34-17.91-16.02
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.00-1.86-3.090.00-1.23-0.95
Other Sources0.180.228.242.020.000.000.130.000.00
Cash from Investing Activities-55.24-31.14-28.31-34.63-38.74-31.36-31.21-19.14-16.97
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-246.44-860.39-154.01-132.64-825.77-44.45-82.286.522.49
Repurchase of Common Pref Stock-294.76-917.39-169.87-144.02-847.85-62.10-98.270.000.00
Sale of Common Pref Stock48.3257.0015.8611.3822.0717.6415.996.522.49
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.00-50.0050.000.000.00-80.44-144.07
Change in Long Term Debt0.000.000.000.000.000.000.00-80.44-144.07
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.00-80.44-144.07
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities-246.44-860.39-154.01-182.64-775.77-44.45-82.28-73.92-141.58
Exchange Rate Effect-1.405.92-2.511.08-6.57-3.970.67-0.17-1.24
Net Change in Cash419.96-172.39423.99217.18-433.04183.54145.85108.64-3.21
Free Cash Flow667.63681.87572.27396.73351.17235.06227.34183.96140.56
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow26.5324.3218.5924.6020.3734.9023.0917.1713.90
Deferred Taxes & Investment Tax Credit-80.77-26.63-25.12-23.01-37.110.5310.053.94

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments705.32502.69652.68497.05285.3546.33
Short Term Receivables447.64441.80394.58402.08373.03377.92
Inventories0.000.000.000.000.000.00
Other Current Assets92.04105.8091.7990.5078.9096.55
Total Current Assets1,245.001,050.291,139.06989.62737.28520.80
Net Property, Plant & Equipment327.55282.96263.36248.87256.76264.99
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets695.35695.51695.66695.82696.05696.29
Deferred Tax Assets3.273.233.2219.2237.1965.79
Other Assets31.4225.2028.3221.9425.7223.80
Total Assets2,302.592,057.182,129.611,975.471,753.011,571.67
Short Term Debt Incl. Current Port. of LT Debt25.4224.0123.8423.2124.9124.89
Accounts Payable43.6837.5334.4328.1426.5243.27
Other Current Liabilities1,427.001,373.891,286.751,292.401,232.481,152.28
Total Current Liabilities1,496.101,435.431,345.011,343.751,283.911,220.44
Long Term Debt146.04120.10122.26113.64119.07124.95
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities13.668.213.929.651.902.02
Other Liabilities61.8659.5860.1049.3554.4951.92
Total Liabilities1,717.661,623.321,531.301,516.401,459.371,399.32
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity584.94433.86598.31459.07293.64172.35
Total Shareholders Equity584.94433.86598.31459.07293.64172.35
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity584.94433.86598.31459.07293.64172.35
Total Liabilities & Stockholders Equity2,302.592,057.182,129.611,975.471,753.011,571.67
Book Value Per Share20.9715.5821.0016.2210.456.15
Tangible Book Value Per Share-3.96-9.40-3.42-8.37-14.32-18.70
Full-Time Employees6,600--6,200--
Price to Book Ratio31.6925.2229.6053.7483.5915.74
Return on Assets25.5427.0922.8722.1322.5723.96
Return on Equity117.88162.1577.2570.2373.7089.38
Return on Invested Capital18.8021.9117.1923.6026.9330.36
Quick Ratio0.830.730.850.740.570.43
Current Ratio0.830.730.850.740.570.43

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income137.46121.36123.87135.13111.1490.26
Depreciation6.586.716.917.137.057.01
Other Funds (Non Cash)14.1810.2611.1710.8612.0511.56
Funds from Operations163.62142.61160.49170.53158.75142.94
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital52.9819.40-8.7022.1287.465.59
Cash from Operating Activities216.60162.01151.79192.65246.21148.53
Capital Expenditures-20.16-23.91-6.81-4.54-10.71-6.11
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.020.030.070.060.050.09
Cash from Investing Activities-20.14-23.89-6.75-4.47-10.66-6.02
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock6.50-288.3412.6722.733.41-540.56
Repurchase of Common Pref Stock0.00-294.760.000.00-4.57-540.91
Sale of Common Pref Stock6.506.4212.6722.737.990.35
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities6.50-288.3412.6722.733.41-540.56
Exchange Rate Effect-0.330.22-2.080.790.062.95
Net Change in Cash202.63-149.99155.63211.70239.02-395.11
Free Cash Flow196.44138.10144.97188.12235.50142.41
Price to Free Cash Flow26.5321.4019.5623.8621.8915.78

Revenue breakdown

Antiviral And Anti Infective2024: 156.46M 2025: 134.94M
Cardiology2024: 230.45M 2025: 239.37M
Central Nervous System2024: 181.98M 2025: 254.84M
Metabolic2024: 457.54M 2025: 744.96M
Oncology2024: 651.24M 2025: 747.59M
Other2024: 431.38M 2025: 408.55M
United States2024: 2.11B 2025: 2.53B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.09%1.4M22.7M258.36K
2026-10-157.10%1.6M22.7M271.09K
2026-09-307.06%1.6M22.6M280.11K
2026-09-157.49%1.7M22.5M294.14K
2026-08-317.44%1.7M22.5M302.58K
2026-08-147.04%1.6M22.4M320.54K
2026-07-317.76%1.7M22.5M344.25K
2026-07-159.52%2.2M23.0M371.20K
2026-06-309.24%2.1M23.0M374.85K
2026-06-159.08%2.1M23.0M362.72K
2026-05-298.93%2.1M23.0M376.32K
2026-05-158.28%1.9M23.0M389.77K
2026-04-306.75%1.6M23.0M430.78K
2026-04-155.87%1.3M23.0M359.36K
2026-03-315.32%1.2M22.9M340.05K
2026-03-136.14%1.4M22.8M322.49K
2026-02-275.63%1.3M22.8M313.46K
2026-02-135.65%1.3M22.8M293.07K
2026-01-305.92%1.3M22.7M236.65K
2026-01-156.05%1.4M22.7M269.70K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call410251.72600.001.9980.000.000.973-0.6670.064
call420241.72500.001.9140.000.000.972-0.6630.066
call4302332390.001.8410.000.000.971-0.6580.068
call4402232290.001.8230.000.000.970-0.6530.071
call450212.9218.9176.241.7061.000.000.968-0.6480.074
call460203208.50.001.6600.000.000.967-0.6420.076
call470191.3199.10.001.5810.000.000.965-0.6370.080
call480181.3189.1140.341.4487.000.000.963-0.6300.083
call490173178.61901.3741.000.000.962-0.6240.086
call500161.3169136.91.3591.000.000.960-0.6170.090
call510152.5159.10.001.2840.000.000.957-0.6090.094
call520141.6149.10.001.1630.000.000.955-0.6010.098
call530131.4139.10.001.1440.000.000.952-0.5920.103
call540121.8129.20.001.0710.000.000.949-0.5830.109
call550111.3119.3132.651.0052.000.000.945-0.5720.114
call560101.6109.4122.950.9393.000.000.936-0.6150.130
call57092.1099.600.000.8870.000.000.891-0.9870.193
call58083.5089.8096.800.8103.000.000.883-0.9570.203
call59073.6079.9071.920.7201.000.000.873-0.9240.215
call60064.1069.9071.080.66515.000.000.861-0.8880.229
call61055.0060.600.000.6160.000.000.845-0.8560.246
call62046.1050.8069.600.5655.000.000.824-0.8260.267
call63037.3043.1025.000.5183.000.000.755-1.0520.325
call64029.3035.2025.900.4945.000.000.707-1.0430.356
call65022.0028.4028.780.50019.000.000.635-1.1230.389
call66016.3023.0020.500.49117.000.000.558-1.1530.408
call67010.9018.0014.000.48821.001.000.477-1.1300.412
call6808.0014.0016.960.49125.000.000.399-1.1000.399
call6902.3010.7021.000.50128.000.000.330-1.0570.374
call7001.309.905.090.5483700.000.281-1.0530.349
call7100.058.006.780.56248.000.000.232-0.9770.315
call7200.057.503.780.61127.000.000.213-1.0370.300
call7300.057.203.190.6620.000.000.197-1.0860.287
call7400.004.901.300.63222.000.000.151-0.8760.242
call7500.004.901.300.68429.000.000.142-0.9090.232
call7600.004.901.050.73417.000.000.134-0.9390.224
call7700.004.902.720.7834.000.000.128-0.9670.216
call7800.004.903.100.8306.000.000.122-0.9920.209
call7900.004.900.810.87617.000.000.117-1.0160.203
call8000.004.9010.000.92117.000.000.112-1.0380.198
call8100.004.900.900.96515.000.000.108-1.0590.193
call8200.004.903.401.00816.000.000.105-1.0790.188
call8300.004.900.001.0490.000.000.102-1.0970.184
call8400.004.900.001.0900.000.000.099-1.1150.180
call8500.004.900.001.1290.000.000.096-1.1320.176
call8600.004.903.301.1680.000.000.093-1.1480.173
call8700.004.900.051.20716.000.000.091-1.1630.169
call8800.004.900.001.2440.000.000.089-1.1780.166
call8900.004.900.001.2810.000.000.087-1.1920.164
put4100.004.900.851.7192.000.00-0.026-0.5970.062
put4200.004.901.801.6562.000.00-0.028-0.6160.066
put4300.004.902.191.5832.000.00-0.029-0.6100.068
put4400.004.901.051.5122.000.00-0.030-0.6040.071
put4500.004.901.341.44110.000.00-0.032-0.5980.074
put4600.004.902.101.3722.000.00-0.033-0.5910.076
put4700.004.900.381.30413.000.00-0.035-0.5840.080
put4800.004.900.051.23811.000.00-0.037-0.5770.083
put4900.004.900.011.1724.000.00-0.038-0.5690.086
put5000.004.900.401.1077.000.00-0.040-0.5610.090
put5100.004.905.461.0442.000.00-0.043-0.5520.094
put5200.004.901.360.9813.000.00-0.045-0.5430.098
put5300.004.900.830.9185.000.00-0.048-0.5330.103
put5400.004.902.230.85710.000.00-0.051-0.5220.109
put5500.002.000.690.7783.000.00-0.060-0.5100.130
put5600.004.901.710.75991.000.00-0.064-0.5530.130
put5700.004.900.930.85342.000.00-0.109-0.9230.193
put5800.004.901.810.68611.000.00-0.090-0.6460.168
put5900.004.905.050.7132050.00-0.127-0.8590.215
put6000.054.902.740.64255.000.00-0.139-0.8210.229
put6100.055.802.080.5717.004.00-0.155-0.7880.246
put6200.054.902.760.49944.002.00-0.176-0.7570.267
put6301.708.807.550.55255.000.00-0.245-0.9820.325
put6402.909.8016.800.49420.000.00-0.293-0.9710.356
put6505.6013.008.600.48558.002.00-0.365-1.0500.389
put66010.8016.9020.000.4745.000.00-0.442-1.0790.408
put67015.0021.0025.100.45010.000.00-0.523-1.0560.412
put68020.7026.9020.000.4496.000.00-0.601-1.0240.399
put69027.4034.0026.400.45917.000.00-0.670-0.9800.374
put70034.3041.0086.300.44716.000.00-0.719-0.9760.349
put71044.3050.200.000.4150.000.00-0.768-0.8980.315
put72052.3058.800.000.4970.000.00-0.787-0.9570.300
put73062.0068.000.000.5180.000.00-0.803-1.0050.287
put74071.7077.900.000.5650.000.00-0.849-0.7940.242
put75081.0088.900.000.6100.000.00-0.858-0.8260.232
put76091.6099.200.000.6580.000.00-0.866-0.8550.224
put770101.51090.000.7040.000.00-0.872-0.8810.216
put780111.6119.60.000.7490.000.00-0.878-0.9060.209
put790121.6129.20.000.7940.000.00-0.883-0.9280.203
put800131.6139.10.000.8360.000.00-0.888-0.9490.198
put8101421500.000.8780.000.00-0.892-0.9690.193
put820152158.20.000.9190.000.00-0.895-0.9870.188
put830161.5169.20.000.9590.000.00-0.898-1.0050.184
put840171.5179.2211.30.9990.000.00-0.901-1.0210.180
put850181.5189.20.001.0370.000.00-0.904-1.0370.176
put860191.5199.20.001.0750.000.00-0.907-1.0520.173
put870201.5209.2240.31.1120.000.00-0.909-1.0660.169
put880211.5219.30.001.1480.000.00-0.911-1.0800.166
put890221.6229.20.001.1840.000.00-0.913-1.0930.164

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-024Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-10-29144Filing for proposed sale of securities under Rule 144.SEC
2026-10-284Statement of changes in beneficial ownership of securities2026-10-26SEC
2026-10-27144Filing for proposed sale of securities under Rule 144.SEC
2026-10-26144Filing for proposed sale of securities under Rule 144.SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-2210-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-218-KCurrent report2026-10-20SEC
2026-10-144Statement of changes in beneficial ownership of securities2026-10-12SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-07SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-29SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-28SCHEDULE 13D/ASEC
2026-09-254Statement of changes in beneficial ownership of securities2026-09-23SEC
2026-09-234Statement of changes in beneficial ownership of securities2026-09-21SEC
2026-09-214Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-26144Filing for proposed sale of securities under Rule 144.SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-21SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-19SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100014.40M3
2026-0900125.86M11
2026-080073.77M17
2026-07008.85M3
2026-060000
2026-05007.36M1
2026-040000
2026-030014.44M1
2026-020000
2026-010000
2025-120017.51M3
2025-1100191.57M17

Institutional holders

Manager% owned
BlackRock, Inc.8.75%
PRICE T ROWE ASSOCIATES INC /MD/7.25%
AQR CAPITAL MANAGEMENT LLC4.48%
VANGUARD PORTFOLIO MANAGEMENT LLC3.97%
VANGUARD CAPITAL MANAGEMENT LLC3.60%
GEODE CAPITAL MANAGEMENT, LLC2.55%
STATE STREET CORP2.49%
Invesco Ltd.2.03%
WASATCH ADVISORS LP1.67%
BAILLIE GIFFORD & CO1.62%

Funds

Fund% owned
iShares Core S&P Mid-Cap ETF2.70%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.54%
VANGUARD SMALL-CAP INDEX FUND1.83%
T. Rowe Price Large-Cap Growth Fund1.32%
Invesco S&P MidCap Quality ETF1.06%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.06%
VANGUARD EXPLORER FUND0.97%
VANGUARD EXTENDED MARKET INDEX FUND0.91%
State Street SPDR S&P MidCap 400SM ETF Trust0.61%
FULLERTHALER BEHAVIORAL SMALL CAP EQUITY0.61%

OakChart. MEDP. Cached 15 minutes.